Back to RIGL
Soleus Capital Management, L.P. → RIGL
Soleus Capital Management, L.P. RIGL Position History
Rigel Pharmaceuticals, Inc. • Healthcare
Quarters held
4
Latest value
$88.8M
Q3 2026
Peak value
$88.8M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $12.9M |
| Q1 2026 | $270K |
| Q2 2026 | $72.1M |
| Q3 2026 | $88.8M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $88.8M | 1.84M | — | — |
| Q2 2026 | $72.1M | 1.84M | — | — |
| Q1 2026 | $270K | 10.0K | — | — |
| Q4 2025 | $12.9M | 300.0K | — | — |
Other funds holding RIGL
$65.4M
$50.1M
$45M
$42.4M
$40.7M
$40.7M